Watchlist Price Alert

Day One Biopharmaceutical... (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

6.49

-0.15 (-2.26%)

At close: Jun 17, 2025, 10:21 AM

Day One Biopharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-95.5M	-188.92M	-142.18M	-72.75M	-43.84M	-16.98M
Depreciation & Amortization	1.56M	383K	531K	199K	155K	n/a
Stock-Based Compensation	48.26M	39.34M	27.24M	13.32M	526K	111K
Other Working Capital	n/a	7.1M	8.05M	1.15M	-489K	430K
Other Non-Cash Items	-59.39M	-7.08M	-2.03M	8M	30.03M	11.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	9.42M	6.56M	2.69M	-357K	444K
Operating Cash Flow	-78.11M	-146.85M	-109.87M	-48.54M	-13.49M	-4.51M
Capital Expenditures	-2.17M	-3.22M	-26K	-8M	-92K	n/a
Cash Acquisitions	n/a	n/a	255.05K	n/a	n/a	n/a
Purchase of Investments	-658.62M	-443.84M	-394.21M	n/a	n/a	n/a
Sales Maturities Of Investments	393.89M	575.44M	139.16M	n/a	n/a	n/a
Other Investing Acitivies	35.9M	-3M	-255.05K	-8M	n/a	n/a
Investing Cash Flow	-230.99M	128.38M	-255.07M	-8M	-92K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	1M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	25.11M	2.59M	4.29M	318K	n/a	n/a
Financial Cash Flow	203.29M	164M	165.9M	297.12M	29.98M	30.91M
Net Cash Flow	-105.82M	145.52M	-199.05M	240.58M	16.4M	26.39M
Free Cash Flow	-80.28M	-150.08M	-109.9M	-56.54M	-13.58M	-4.51M